Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti ...

The main risk factors for tonsil cancer are smoking, drinking alcohol and infection with the human papilloma virus (HPV). Most tonsil cancers are a type called squamous cell carcinoma. A small number ...

The project aims to explore how nature and outdoor activities impact the physical and mental health and wellbeing of young people who have been affected by cancer. These are people aged between 16 ...

Innovative Immunotherapy Shows Promise in Early Clinical Trial for Breast Cancer Dec. 5, 2024 — A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer.

Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

Cutaneous T-cell lymphoma is a primary cutaneous lymphoma (meaning it starts in the skin). It is a rare cancer that begins in the T cells (a white blood cell). It can lead to rash-like redness, scaly ...

After hours: February 10 at 6:40:00 PM EST ...

Neither here nor there? Your mind wanders as the moon and Jupiter clash. Find an anchor point. The vibes are high, and your mood is restless. If you don’t ground down, you risk getting drawn ...